Cargando…
High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution
Protein glycosylation can impact the efficacy and safety of biotherapeutics and therefore needs to be well characterized and monitored throughout the drug product life cycle. Glycosylation is commonly assessed by fluorescent labeling of released glycans, which provides comprehensive information of t...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372583/ https://www.ncbi.nlm.nih.gov/pubmed/32458729 http://dx.doi.org/10.1177/2472630320922803 |
_version_ | 1783561343751684096 |
---|---|
author | Zhang, Ximo Reed, Corey E. Birdsall, Robert E. Yu, Ying Qing Chen, Weibin |
author_facet | Zhang, Ximo Reed, Corey E. Birdsall, Robert E. Yu, Ying Qing Chen, Weibin |
author_sort | Zhang, Ximo |
collection | PubMed |
description | Protein glycosylation can impact the efficacy and safety of biotherapeutics and therefore needs to be well characterized and monitored throughout the drug product life cycle. Glycosylation is commonly assessed by fluorescent labeling of released glycans, which provides comprehensive information of the glycoprofile but can be resource-intensive regarding sample preparation, data acquisition, and data analysis. In this work, we evaluate a comprehensive solution from sample preparation to data reporting using a liquid chromatography–mass spectrometry (LC-MS)-based analytical platform for increased productivity in released glycan analysis. To minimize user intervention and improve assay robustness, a robotic liquid handling platform was used to automate the release and labeling of N-glycans within 2 h. To further increase the throughput, a 5 min method was developed on a liquid chromatography–fluorescence–mass spectrometry (LC-FLR-MS) system using an integrated glycan library based on retention time and accurate mass. The optimized method was then applied to 48 released glycan samples derived from six batches of infliximab to mimic comparability testing encountered in the development of biopharmaceuticals. Consistent relative abundance of critical species such as high mannose and sialylated glycans was obtained for samples within the same batch (mean percent relative standard deviation [RSD] = 5.3%) with data being acquired, processed, and reported in an automated manner. The data acquisition and analysis of the 48 samples were completed within 6 h, which represents a 90% improvement in throughput compared with conventional LC-FLR-based methods. Together, this workflow facilitates the rapid screening of glycans, which can be deployed at various stages of drug development such as process optimization, bioreactor monitoring, and clone selections, where high-throughput and improved productivity are particularly desired. |
format | Online Article Text |
id | pubmed-7372583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-73725832020-08-13 High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution Zhang, Ximo Reed, Corey E. Birdsall, Robert E. Yu, Ying Qing Chen, Weibin SLAS Technol Original Research Protein glycosylation can impact the efficacy and safety of biotherapeutics and therefore needs to be well characterized and monitored throughout the drug product life cycle. Glycosylation is commonly assessed by fluorescent labeling of released glycans, which provides comprehensive information of the glycoprofile but can be resource-intensive regarding sample preparation, data acquisition, and data analysis. In this work, we evaluate a comprehensive solution from sample preparation to data reporting using a liquid chromatography–mass spectrometry (LC-MS)-based analytical platform for increased productivity in released glycan analysis. To minimize user intervention and improve assay robustness, a robotic liquid handling platform was used to automate the release and labeling of N-glycans within 2 h. To further increase the throughput, a 5 min method was developed on a liquid chromatography–fluorescence–mass spectrometry (LC-FLR-MS) system using an integrated glycan library based on retention time and accurate mass. The optimized method was then applied to 48 released glycan samples derived from six batches of infliximab to mimic comparability testing encountered in the development of biopharmaceuticals. Consistent relative abundance of critical species such as high mannose and sialylated glycans was obtained for samples within the same batch (mean percent relative standard deviation [RSD] = 5.3%) with data being acquired, processed, and reported in an automated manner. The data acquisition and analysis of the 48 samples were completed within 6 h, which represents a 90% improvement in throughput compared with conventional LC-FLR-based methods. Together, this workflow facilitates the rapid screening of glycans, which can be deployed at various stages of drug development such as process optimization, bioreactor monitoring, and clone selections, where high-throughput and improved productivity are particularly desired. SAGE Publications 2020-05-27 2020-08 /pmc/articles/PMC7372583/ /pubmed/32458729 http://dx.doi.org/10.1177/2472630320922803 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Zhang, Ximo Reed, Corey E. Birdsall, Robert E. Yu, Ying Qing Chen, Weibin High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from Biotherapeutics Using an Automated LC-MS-Based Solution |
title | High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from
Biotherapeutics Using an Automated LC-MS-Based Solution |
title_full | High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from
Biotherapeutics Using an Automated LC-MS-Based Solution |
title_fullStr | High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from
Biotherapeutics Using an Automated LC-MS-Based Solution |
title_full_unstemmed | High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from
Biotherapeutics Using an Automated LC-MS-Based Solution |
title_short | High-Throughput Analysis of Fluorescently Labeled N-Glycans Derived from
Biotherapeutics Using an Automated LC-MS-Based Solution |
title_sort | high-throughput analysis of fluorescently labeled n-glycans derived from
biotherapeutics using an automated lc-ms-based solution |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372583/ https://www.ncbi.nlm.nih.gov/pubmed/32458729 http://dx.doi.org/10.1177/2472630320922803 |
work_keys_str_mv | AT zhangximo highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution AT reedcoreye highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution AT birdsallroberte highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution AT yuyingqing highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution AT chenweibin highthroughputanalysisoffluorescentlylabelednglycansderivedfrombiotherapeuticsusinganautomatedlcmsbasedsolution |